Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Tropifexor Monotherapy	54
Overall Study	STARTED	Licogliflozin Monotherapy	55
Overall Study	STARTED	Combination Therapy	84
Overall Study	STARTED	Placebo	41
Overall Study	COMPLETED	Tropifexor Monotherapy	25
Overall Study	COMPLETED	Licogliflozin Monotherapy	33
Overall Study	COMPLETED	Combination Therapy	42
Overall Study	COMPLETED	Placebo	21
Overall Study	NOT COMPLETED	Tropifexor Monotherapy	29
Overall Study	NOT COMPLETED	Licogliflozin Monotherapy	22
Overall Study	NOT COMPLETED	Combination Therapy	42
Overall Study	NOT COMPLETED	Placebo	20

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04065841/flow